文献速递类风湿关节炎

类风湿关节炎临床试验中强化运动剂量证据的系统综述

A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

结果显示仅4项(12.5%)采用剂量递增设计探索最优剂量反应,20项(62.5%)未报告剂量依据,且所报告证据的质量、一致性和适用性存在方法学问题。

要点

  • 多数RCT未报告强化运动剂量的证据依据。
  • 仅少数RCT采用剂量递增设计确定最优剂量反应。
  • 所引用证据常不适用于临床人群且剂量与证据推荐不一致。

核心结论

  • 多数RCT未报告支持运动剂量的证据,且所报告证据常不适用于临床人群。
  • 运动剂量在RCT评估前可能未针对临床人群进行优化。

研究设计与样本

  • 系统综述检索六个数据库2000年1月1日至2019年4月3日的文献。
  • 对引用以支持剂量的证据来源进行质量、一致性和适用性评价。

主要发现

  • 所报告证据的质量、一致性和适用性存在方法学担忧。
  • 所用剂量常与支持证据报告或推荐的剂量不同。

临床怎么用

  • 解读RA强化运动RCT时需关注剂量依据是否充分且适用于临床人群。
  • 临床借鉴RCT运动剂量时应评估其证据来源的质量与适用性。

局限性

  • 仅检索2000年1月1日至2019年4月3日六个数据库的文献。
  • 仅纳入以强化运动为主要干预或对照成分的RCT。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We aimed to evaluate the evidence reported to underpin exercise dose in randomised controlled trials (RCTs) using strengthening exercise in RA. We searched six different databases between 1 January 2000 and 3 April 2019. We included RCTs, where a main component of the intervention and/or control used strengthening exercise. Evidence sources cited to underpin dose were judged for their quality, consistency and applicability. Thirty-two RCTs were reviewed. Four (12.5%) piloted the intervention without using dose-escalation designs to determine optimal dose-response. Twenty (62.5%) reported no evidence underpinning dose. Where reported, quality, consistency and applicability of the underpinning evidence was a cause for methodological concern. The majority of RCTs did not report the evidence underpinning dose. When reported, the evidence was often not applicable to the clinical population. Frequently, the dose used differed to the dose reported/recommended by the underpinning evidence. Our findings illustrate exercise dose may not be optimised for use with clinical populations prior to evaluation by RCT.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Boniface G, Gandhi V, Norris M, et al. A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis. Rheumatology (Oxford). 2020. PMID: 32780816. doi:10.1093/rheumatology/keaa150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。